Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 4

Latroeggtoxin-VI improves depression by regulating the composition and function of gut microbiota in a mouse model of depression Open Access

Abstract

Depression has become one of the mental diseases that seriously affect human health. Its mechanism is very complex, and many factors influence the condition. An imbalance of the gut microbiota is being considered as a factor that impacts the occurrence and progression of depression. Future therapies may therefore tap into this connection, treating depression through manipulation of the gut microbiome.

Latroeggtoxin-VI (LETX-VI), a proteinaceous neurotoxin from eggs, was previously demonstrated to inhibit excessive inflammation and improve depression behaviours, suggesting that it might be able to regulate the balance of gut microbiota. The aim of this study was to explore the effects of LPS and LETX-VI on depressive behaviours and gut microbiota and to analyse correlations between changes in the gut microbiota and depressive behaviours.

A murine model of depression was established, and the effects of LPS and LETX-VI treatment on depressive behaviours and gut microbiota were investigated.

In the murine model, depressive behaviour was induced by LPS; the ratio of to (F/B) and the number of pro-inflammatory bacteria in the gut microbiota increased (<0.01), while butyric acid-producing bacteria with anti-inflammatory effect decreased (<0.05). Furthermore, the metabolic function of the gut microbiota was disrupted, and the level of virulence factors among gut microbiota was up-regulated (<0.05). Association analysis showed that the changes in the composition and function of gut microbiota were closely related to the depression phenotype of mice, suggesting that the abnormal function of gut microbiota is linked to depression. However, when LETX-VI was applied before LPS injection, the LPS-induced changes in the gut microbiota were alleviated, and the depressive behaviour greatly improved.

LETX-VI can prevent depressive behaviour by regulating the composition and/or function of the gut microbiota.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): depression , depression mouse model , depressive behaviour , gut microbiota and latroeggtoxin-VI
Funding
This study was supported by the:
  • National Natural Science Foundation of China (Award 31870770)
    • Principle Award Recipient: WangXianchun
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001977
2025-04-09
2025-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/4/jmm001977.html?itemId=/content/journal/jmm/10.1099/jmm.0.001977&mimeType=html&fmt=ahah

References

  1. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370:851–858 [View Article] [PubMed]
     [Google Scholar]
  2. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 2015; 48:186–194 [View Article] [PubMed]
     [Google Scholar]
  3. Nikolova VL, Smith MRB, Hall LJ, Cleare AJ, Stone JM et al. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. Jama Psychiat 2021; 78:1343 [View Article]
     [Google Scholar]
  4. Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG et al. The gut microbiota in anxiety and depression - a systematic review. Clin Psychol Rev 2021; 83:101943 [View Article] [PubMed]
     [Google Scholar]
  5. Ghaisas S, Maher J, Kanthasamy A. Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 2016; 158:52–62 [View Article] [PubMed]
     [Google Scholar]
  6. Settanni CR, Ianiro G, Bibbò S, Cammarota G, Gasbarrini A. Gut microbiota alteration and modulation in psychiatric disorders: current evidence on fecal microbiota transplantation. Prog Neuropsychopharmacol Biol Psychiatry 2021; 109:110258 [View Article] [PubMed]
     [Google Scholar]
  7. Naseer MI, Bibi F, Alqahtani MH, Chaudhary AG, Azhar EI et al. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer’s disease. CNS Neurol Disord Drug Targets 2014; 13:305–311 [View Article] [PubMed]
     [Google Scholar]
  8. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials. Gut Pathog 2013; 5:4–16 [View Article] [PubMed]
     [Google Scholar]
  9. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38:1–12 [View Article] [PubMed]
     [Google Scholar]
  10. Kelly JR, Borre Y, O’ Brien C, Patterson E, El Aidy S et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 2016; 82:109–118 [View Article]
     [Google Scholar]
  11. Zheng P, Zeng B, Zhou C, Liu M, Fang Z et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 2016; 21:786–796 [View Article] [PubMed]
     [Google Scholar]
  12. Choi AJS, Ryter SW. Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases. Mol Cells 2014; 37:441–448 [View Article] [PubMed]
     [Google Scholar]
  13. Cai T, Zheng S-P, Shi X, Yuan L-Z, Hu H et al. Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression. Front Cell Infect Microbiol 2022; 12:900652 [View Article] [PubMed]
     [Google Scholar]
  14. Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry 2020; 25:131–147 [View Article]
     [Google Scholar]
  15. Westfall S, Pasinetti GM. The gut microbiota links dietary polyphenols with management of psychiatric mood disorders. Front Neurosci 2019; 13:1196 [View Article] [PubMed]
     [Google Scholar]
  16. Skonieczna-Żydecka K, Grochans E, Maciejewska D, Szkup M, Schneider-Matyka D et al. Faecal short chain fatty acids profile is changed in polish depressive women. Nutrients 2018; 10:1939 [View Article] [PubMed]
     [Google Scholar]
  17. Zheng X, Cheng Y, Chen Y, Yue Y, Li Y et al. Ferulic acid improves depressive-like behavior in prenatally-stressed offspring rats via anti-inflammatory activity and HPA axis. Int J Mol Sci 2019; 20:493 [View Article] [PubMed]
     [Google Scholar]
  18. Lee Y-B, Cho Y-J, Kim J-K. The unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. Biomed Pharmacother 2025; 182:117748 [View Article]
     [Google Scholar]
  19. Sun Y, Yan T, Gong G, Li Y, Zhang J et al. Antidepressant-like effects of Schisandrin on lipopolysaccharide-induced mice : gut microbiota, short chain fatty acid and TLR4/NF-κB signaling pathway. Int Immunopharmacol 2020; 89:107029 [View Article]
     [Google Scholar]
  20. Xiao Q, Shu R, Wu C, Tong Y, Xiong Z et al. Crocin-I alleviates the depression-like behaviors probably via modulating “microbiota-gut-brain” axis in mice exposed to chronic restraint stress. J Affect Disord 2020; 276:476–486 [View Article] [PubMed]
     [Google Scholar]
  21. Agyei D, Ahmed I, Akram Z, Iqbal HMN, Danquah MK. Protein and peptide biopharmaceuticals: an overview. Protein Pept Lett 2017; 24:94–101 [View Article] [PubMed]
     [Google Scholar]
  22. Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des 2013; 81:136–147 [View Article] [PubMed]
     [Google Scholar]
  23. Wang H, Zhai Y, Lei Z, Chen S, Sun M et al. Latroeggtoxin-VI protects nerve cells and prevents depression by inhibiting NF-κB signaling pathway activation and excessive inflammation. Front Immunol 2023; 14:1171351 [View Article]
     [Google Scholar]
  24. Yan S, Tang X, Yu D, Wang H, Meng W et al. Gene cloning, heterologous expression and activity identification of latroeggtoxin-Ⅵ. Sheng Wu Gong Cheng Xue Bao 2021; 37:635–645 [View Article] [PubMed]
     [Google Scholar]
  25. Wang Z, Zhang Q, Yuan L, Wang S, Liu L et al. The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration. Behav Brain Res 2014; 274:282–290 [View Article]
     [Google Scholar]
  26. O’Connor JC, Lawson MA, André C, Moreau M, Lestage J et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009; 14:511–522 [View Article] [PubMed]
     [Google Scholar]
  27. Frenois F, Moreau M, O’Connor J, Lawson M, Micon C et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007; 32:516–531 [View Article] [PubMed]
     [Google Scholar]
  28. Yin R, Zhang K, Li Y, Tang Z, Zheng R et al. Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation. Front Immunol 2023; 14:1181973 [View Article] [PubMed]
     [Google Scholar]
  29. Liu M-Y, Yin C-Y, Zhu L-J, Zhu X-H, Xu C et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 2018; 13:1686–1698 [View Article] [PubMed]
     [Google Scholar]
  30. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 2008; 5:15 [View Article] [PubMed]
     [Google Scholar]
  31. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985; 85:367–370 [View Article] [PubMed]
     [Google Scholar]
  32. Wang Z, Gu J, Wang X, Xie K, Luan Q et al. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol Biochem Behav 2013; 112:104–110 [View Article] [PubMed]
     [Google Scholar]
  33. Peng W, Yi P, Yang J, Xu P, Wang Y et al. Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer’s disease using 16S rRNA gene and metagenomic sequencing analysis. Aging 2018; 10:4054–4065 [View Article]
     [Google Scholar]
  34. Li R, Yu C, Li Y, Lam T-W, Yiu S-M et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009; 25:1966–1967 [View Article] [PubMed]
     [Google Scholar]
  35. Hyatt D, Chen G-L, Locascio PF, Land ML, Larimer FW et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinf 2010; 11:119 [View Article] [PubMed]
     [Google Scholar]
  36. Fu L, Niu B, Zhu Z, Wu S, Li W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 2012; 28:3150–3152 [View Article] [PubMed]
     [Google Scholar]
  37. Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P et al. Package ‘Vegan’ Title Community Ecology Package Version 2.5–7 R; 2020
     [Google Scholar]
  38. Vidaillac C, Chotirmall SH. Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies. Expert Rev Respir Med 2021; 15:649–662 [View Article] [PubMed]
     [Google Scholar]
  39. Sola-Landa A, Moura RS, Martín JF. The two-component PhoR-PhoP system controls both primary metabolism and secondary metabolite biosynthesis in Streptomyces lividans. Proc Natl Acad Sci USA 2003; 100:6133–6138 [View Article] [PubMed]
     [Google Scholar]
  40. Goyal R, Das AK, Singh R, Singh PK, Korpole S et al. Phosphorylation of PhoP protein plays direct regulatory role in lipid biosynthesis of Mycobacterium tuberculosis. J Biol Chem 2011; 286:45197–45208 [View Article] [PubMed]
     [Google Scholar]
  41. Zahrt TC, Deretic V. Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc Natl Acad Sci USA 2001; 98:12706–12711 [View Article] [PubMed]
     [Google Scholar]
  42. Sharma A, Rustad T, Mahajan G, Kumar A, Rao KVS et al. Towards understanding the biological function of the unusual chaperonin Cpn60.1 (GroEL1) of Mycobacterium tuberculosis. Tuberculosis 2016; 97:137–146 [View Article] [PubMed]
     [Google Scholar]
  43. Guzman-Verri C, Manterola L, Sola-Landa A, Parra A, Cloeckaert A et al. The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci USA 2002; 99:12375–12380 [View Article] [PubMed]
     [Google Scholar]
  44. Viadas C, Rodríguez MC, Sangari FJ, Gorvel J-P, García-Lobo JM et al. Transcriptome analysis of the Brucella abortus BvrR/BvrS two-component regulatory system. PLoS One 2010; 5:e10216 [View Article] [PubMed]
     [Google Scholar]
  45. Qin S, Xiao W, Zhou C, Pu Q, Deng X et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther 2022; 7:199 [View Article] [PubMed]
     [Google Scholar]
  46. Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev 2016; 40:480–493 [View Article] [PubMed]
     [Google Scholar]
  47. Ramjeet M, Deslandes V, St Michael F, Cox AD, Kobisch M et al. Truncation of the lipopolysaccharide outer core affects susceptibility to antimicrobial peptides and virulence of Actinobacillus pleuropneumoniae serotype 1. J Biol Chem 2005; 280:39104–39114 [View Article] [PubMed]
     [Google Scholar]
  48. Murray GL, Srikram A, Henry R, Hartskeerl RA, Sermswan RW et al. Mutations affecting Leptospira interrogans lipopolysaccharide attenuate virulence. Mol Microbiol 2010; 78:701–709 [View Article] [PubMed]
     [Google Scholar]
  49. Bahar O, Levi N, Burdman S. The cucurbit pathogenic bacterium Acidovorax citrulli requires a polar flagellum for full virulence before and after host-tissue penetration. Mol Plant Microbe Interact 2011; 24:1040–1050 [View Article] [PubMed]
     [Google Scholar]
  50. Ozer E, Yaniv K, Chetrit E, Boyarski A, Meijler MM et al. An inside look at a biofilm: Pseudomonas aeruginosa flagella biotracking. Sci Adv 2021; 7:eabg8581 [View Article] [PubMed]
     [Google Scholar]
  51. Allen AG, Thomas RM, Cadisch JT, Maskell DJ. Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Mol Microbiol 1998; 29:27–38 [View Article] [PubMed]
     [Google Scholar]
  52. Banemann A, Deppisch H, Gross R. The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun 1998; 66:5607–5612 [View Article] [PubMed]
     [Google Scholar]
  53. Harvill ET, Preston A, Cotter PA, Allen AG, Maskell DJ et al. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun 2000; 68:6720–6728 [View Article] [PubMed]
     [Google Scholar]
  54. Burns VC, Pishko EJ, Preston A, Maskell DJ, Harvill ET. Role of Bordetella O antigen in respiratory tract infection. Infect Immun 2003; 71:86–94 [View Article] [PubMed]
     [Google Scholar]
  55. Schaeffer LM, McCormack FX, Wu H, Weiss AA. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol 2004; 173:1959–1965 [View Article] [PubMed]
     [Google Scholar]
  56. Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303:G675–85 [View Article] [PubMed]
     [Google Scholar]
  57. Nahon S, Lahmek P, Durance C, Olympie A, Lesgourgues B et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:2086–2091 [View Article] [PubMed]
     [Google Scholar]
  58. Modabbernia M-J, Mansour-Ghanaei F, Imani A, Mirsafa-Moghaddam S-A, Sedigh-Rahimabadi M et al. Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran. BMC Res Notes 2012; 5:112 [View Article] [PubMed]
     [Google Scholar]
  59. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155:1451–1463 [View Article] [PubMed]
     [Google Scholar]
  60. Brenner SR. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horses. Med Hypotheses 2013; 80:103 [View Article] [PubMed]
     [Google Scholar]
  61. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008; 9:387–402 [View Article] [PubMed]
     [Google Scholar]
  62. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008; 452:872–876 [View Article] [PubMed]
     [Google Scholar]
  63. Zheng P, Zeng B, Liu M, Chen J, Pan J et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv 2019; 5:eaau8317 [View Article] [PubMed]
     [Google Scholar]
  64. Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linløkken A et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 2014; 26:1155–1162 [View Article] [PubMed]
     [Google Scholar]
  65. Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 2019; 4:396–403 [View Article] [PubMed]
     [Google Scholar]
  66. Park HJ, Jeong O-Y, Chun SH, Cheon YH, Kim M et al. Butyrate improves skin/lung fibrosis and intestinal dysbiosis in bleomycin-induced mouse models. IJMS 2021; 22:2765 [View Article]
     [Google Scholar]
  67. Dang G, Wu W, Zhang H, Everaert N. A new paradigm for a new simple chemical: butyrate & immune regulation. Food Funct 2021; 12:12181–12193 [View Article] [PubMed]
     [Google Scholar]
  68. Wu L, Seon GM, Kim Y, Choi SH, Vo QC et al. Enhancing effect of sodium butyrate on phosphatidylserine-liposome-induced macrophage polarization. Inflamm Res 2022; 71:641–652 [View Article] [PubMed]
     [Google Scholar]
  69. Guo X, Huang C, Xu J, Xu H, Liu L et al. Gut microbiota is a potential biomarker in inflammatory bowel disease. Front Nutr 2021; 8:818902 [View Article] [PubMed]
     [Google Scholar]
  70. Zhang Y, Fan Q, Hou Y, Zhang X, Yin Z et al. Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling. Brain Behav Immun 2022; 102:11–22 [View Article]
     [Google Scholar]
  71. Brown EM, Ke X, Hitchcock D, Jeanfavre S, Avila-Pacheco J et al. Bacteroides-derived sphingolipids are critical for maintaining intestinal homeostasis and symbiosis. Cell Host Microbe 2019; 25:668–680 [View Article] [PubMed]
     [Google Scholar]
  72. Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R et al. Gut microbiota and metabolome alterations associated with Parkinson's disease. mSystems 2020; 5:e00561-20 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001977
Loading
Latroeggtoxin-VI improves depression by regulating the composition and function of gut microbiota in a mouse model of depression
J. Med. Microbiol. 74, 001977 (2025); https://doi.org/10.1099/jmm.0.001977
/content/journal/jmm/10.1099/jmm.0.001977
/content/journal/jmm/10.1099/jmm.0.001977
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error